BioNTech and Moderna lobby the EU, Swiss and UK regulatory agencies to stop mRNA injections being classified as gene therapy
BioNTech and Moderna are frantically lobbying the European Parliament to stop a reclassification of mRNA injections as “gene therapy” in the upcoming revision to the European Union’s (“EU’s”) pharmaceutical legislation.
Read More